|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Restructuring expenses | |||||
| Impairment charges (reversals) - net | |||||
| Impairment charge | |||||
| Loss (gain) on sale of assets | |||||
| Operating income | |||||
| Interest expense | |||||
| Pension termination charge | |||||
| Other expense - net | |||||
| Earnings before income taxes | |||||
| Provision for income taxes | |||||
| Net earnings | |||||
| Net earnings attributable to noncontrolling interest | |||||
| Net earnings attributable to Modine | |||||
| Net earnings per share attributable to Modine shareholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...